Leonardo Borras

Title: Leonardo Borras: Innovator in Antibody Research

Introduction

Leonardo Borras is a prominent inventor based in Birmensdorf, Switzerland. He has made significant contributions to the field of antibody research, holding a total of three patents. His work focuses on innovative solutions for treating various diseases, particularly in the realm of ocular and cancer therapies.

Latest Patents

Borras's latest patents include groundbreaking inventions such as "Anti-C3 antibodies and antigen-binding fragments thereof and their uses for treating eye or ocular diseases." This invention relates to antibodies that specifically target complement C3, providing methods for treating a range of diseases or disorders. Another notable patent is "MAGE-A4 peptide dual T cell engagers," which describes antigen-binding proteins that target Melanoma-Associated Antigen A4 (MAGE-A4) peptide-MHC. This patent also outlines multispecific antigen-binding proteins that can be used in cancer treatment.

Career Highlights

Throughout his career, Leonardo Borras has worked with reputable companies, including Cdr-life AG and Boehringer Ingelheim International GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of biotechnology.

Collaborations

Borras has collaborated with notable colleagues such as Anna Maria Sobieraj and Fabian Bert Scheifele. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Leonardo Borras is a distinguished inventor whose work in antibody research has the potential to transform treatments for ocular diseases and cancer. His innovative patents and collaborations highlight his commitment to advancing medical science.